ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,994 | +140.8% | 99,502 | +251.6% | 0.00% | – |
| Q2 2023 | $83,473 | +42.2% | 28,296 | +20.5% | 0.00% | – |
| Q1 2023 | $58,718 | -82.0% | 23,487 | -77.2% | 0.00% | – |
| Q4 2022 | $326,016 | +68.9% | 102,844 | +57.9% | 0.00% | – |
| Q3 2022 | $193,000 | +11.6% | 65,122 | +14.6% | 0.00% | – |
| Q2 2022 | $173,000 | -77.2% | 56,835 | +0.9% | 0.00% | – |
| Q1 2022 | $760,000 | +341.9% | 56,315 | +326.8% | 0.00% | – |
| Q4 2021 | $172,000 | -73.3% | 13,195 | -80.8% | 0.00% | – |
| Q3 2021 | $644,000 | +4853.8% | 68,694 | +5351.9% | 0.00% | – |
| Q2 2021 | $13,000 | 0.0% | 1,260 | +80.0% | 0.00% | – |
| Q1 2021 | $13,000 | -99.8% | 700 | -99.6% | 0.00% | -100.0% |
| Q4 2020 | $5,612,000 | +1117.4% | 163,852 | +556.2% | 0.00% | – |
| Q3 2020 | $461,000 | – | 24,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |